Key result
Mechanical tricuspid valves linked to ~121% higher 5-year failure risk versus bioprostheses alongside increased thrombosis.
Why the study?
The choice between mechanical and biological prostheses for tricuspid valve replacement remains debated due to distinct advantages and disadvantages, and TVR carries high procedural risk.
Do mechanical prostheses compared to biological prostheses improve clinical outcomes in patients undergoing tricuspid valve replacement?
Population
8316 prostheses in 37 studies
Comparison
Mechanical vs biological valves in the tricuspid position
Design
Systematic review and meta-analysis
Authors
Loading...
Supports bioprostheses over mechanical valves in tricuspid replacement to lower thrombosis and failure risks; challenges prior durability assumptions without survival gain.
Meta-Analysis (n=8,316)
Yes
Do mechanical prostheses compared to biological prostheses improve clinical outcomes in patients undergoing tricuspid valve replacement?
Effect estimate: RR 2.21 (95% CI 1.38-3.56)
p-value: p=0.001
In tricuspid valve replacement, mechanical valves are associated with significantly higher risks of 5-year valve failure and thrombotic events compared to bioprostheses, without a long-term survival benefit.
Qadeer et al. (2024) conducted a meta-analysis in Tricuspid valve replacement (n=8,316). Mechanical prostheses vs. Biological prostheses was evaluated on 5-year valve failure (RR 2.21, 95% CI 1.38-3.56, p=0.001). Mechanical valves for tricuspid valve replacement were associated with a significantly increased risk of 5-year valve failure (RR 2.21) and a six-fold elevated risk of thrombotic events (RR 6.29) compared to bioprostheses.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: